To the best of our knowledge, this will be the first study to unravel antiplatelet and antithrombotic properties of L. cuneata via inhibition of integrin αIIbβ3, MAPK, PI3K/AKT pathways, and FeCl3-induced murine thrombosis model. The gene discussed is AKT1; the disease is deep vein thrombosis.